[Other] CRISPR＊s next act: the companies editing the epigenome to treat disease |
|
This post will be closed automatically in 2026-07-06 11:19
Reward30points
|
20
Rapidly progressive anti-GBM disease secondary to long-standing rheumatoid arthritis: a case report and literature review
20
Expression of Plasma miRNA-221 in Colorectal Carcinoma Patients and its Diagnostic Significance in Comparison with p53 Expression
20
Association of Weight Loss and Physical Activity With A1C Reduction in a Diabetes Prevention Program: A Secondary Analysis of a Randomized Clinical Trial
20
Glycemic Improvement and Active Charcot Neuroarthropathy: Osteocalcin as a Candidate Biomarker of Transient Skeletal Vulnerability
20
Microplastics occurrence, abundance, and typology across various locations of the Akaki River during the wet season
